Aragen, a contract research development and manufacturing organization (CRDMO), announced that it was setting up a new biologics manufacturing facility in Bangalore, India as part of a $30 million investment. The new 160,000 m2 facility will include process development labs and multiple good manufacturing practice (GMP) suites, equipped to conduct intensified bioprocessing using single-use bioreactors and will have advanced downstream purification capability. Source: Biopharm International 2/11/2023